444 related articles for article (PubMed ID: 17719699)
1. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Sadashiva CT; Chandra JN; Kavitha CV; Thimmegowda A; Subhash MN; Rangappa KS
Eur J Med Chem; 2009 Dec; 44(12):4848-54. PubMed ID: 19717214
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Mythri RB; Venkateshappa C; Subhash MN; Rangappa KS
Bioorg Med Chem; 2009 Aug; 17(15):5526-34. PubMed ID: 19595599
[TBL] [Abstract][Full Text] [Related]
4. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models.
Kumar YC; Malviya M; Chandra JN; Sadashiva CT; Kumar CS; Prasad SB; Prasanna DS; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 May; 16(9):5157-63. PubMed ID: 18359231
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Asha D; Chandra JN; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 Aug; 16(15):7095-101. PubMed ID: 18640043
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
7. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Hernandez CM; Terry AV
Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
[TBL] [Abstract][Full Text] [Related]
9. A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models.
Hu Y; Xia Z; Sun Q; Orsi A; Rees D
Brain Res; 2005 Oct; 1060(1-2):26-39. PubMed ID: 16226729
[TBL] [Abstract][Full Text] [Related]
10. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
11. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
12. Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
Bromidge SM; Brown F; Cassidy F; Clark MS; Dabbs S; Hadley MS; Hawkins J; Loudon JM; Naylor CB; Orlek BS; Riley GJ
J Med Chem; 1997 Dec; 40(26):4265-80. PubMed ID: 9435896
[TBL] [Abstract][Full Text] [Related]
13. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
[TBL] [Abstract][Full Text] [Related]
14. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors.
Fisher A
Neurodegener Dis; 2008; 5(3-4):237-40. PubMed ID: 18322400
[TBL] [Abstract][Full Text] [Related]
15. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
[TBL] [Abstract][Full Text] [Related]
16. Regulation of M1-receptor mRNA stability by smilagenin and its significance in improving memory of aged rats.
Hu Y; Wang Z; Zhang R; Wu P; Xia Z; Orsi A; Rees D
Neurobiol Aging; 2010 Jun; 31(6):1010-9. PubMed ID: 18676061
[TBL] [Abstract][Full Text] [Related]
17. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
18. AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.
Fisher A; Bezprozvanny I; Wu L; Ryskamp DA; Bar-Ner N; Natan N; Brandeis R; Elkon H; Nahum V; Gershonov E; LaFerla FM; Medeiros R
Neurodegener Dis; 2016; 16(1-2):95-110. PubMed ID: 26606130
[TBL] [Abstract][Full Text] [Related]
19. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice.
Anagnostaras SG; Murphy GG; Hamilton SE; Mitchell SL; Rahnama NP; Nathanson NM; Silva AJ
Nat Neurosci; 2003 Jan; 6(1):51-8. PubMed ID: 12483218
[TBL] [Abstract][Full Text] [Related]
20. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
Shiozaki K; Iseki E
J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
